✦ LIBER ✦

480 Treatment with adefovir alone or in combination with lamivudine in chronic hepatitis B lamivudine-resistant patients: Results after two years

✍ Scribed by V. Barbon; A. Marzano; S. Carenzi; M. Lagget; C. Alessandria; A. Olivero; S. Gaia; A. Ciancio; A. Smedile; M. Rizzetto

Book ID: 117374757
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 254 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80480-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adefovir dipivoxil alone or in combinati

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B

✍ Marion G. Peters; H.W. Hann; Paul Martin; E.Jenny Heathcote; P. Buggisch; R. Rub 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Extended treatment with lamivudine and a

Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ Robert P. Perrillo; Hie-Won Hann; Eugene Schiff; David Mutimer; Bernard Willems; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 309 KB

Low risk of adefovir resistance in lamiv

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up

✍ Hiromi Yatsuji; Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 238 KB

501 Adefovir dipivoxil alone or in combi

501 Adefovir dipivoxil alone or in combination with lamivudine in HBeAg negative patients with lamivudine resistant chronic hepatitis B: A prospective, randomized study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Lamivudine-resistant chronic hepatitis B

Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine

✍ Silvia Gaia; Valeria Barbon; Antonina Smedile; Antonella Olivero; Silvia Carenzi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Efficacy of entecavir in patients with c

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

✍ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/